Cargando…
A pull-down and slot blot-based screening system for inhibitor compounds of the podoplanin-CLEC-2 interaction
Podoplanin, a transmembrane glycoprotein, is overexpressed in certain types of tumors and induces platelet aggregation by binding to C-type lectin-like receptor 2 (CLEC-2) on the platelet membrane. Activated platelets release granule components, which in turn, trigger epithelial-mesenchymal transiti...
Autores principales: | Watanabe, Nobuo, Kidokoro, Masako, Suzuki, Yusuke, Tanaka, Makiko, Inoue, Shigeaki, Tsukamoto, Hideo, Hirayama, Noriaki, Hsieh, Pei-Wen, Tseng, Ching-Ping, Nakagawa, Yoshihide, Inokuchi, Sadaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760769/ https://www.ncbi.nlm.nih.gov/pubmed/31553741 http://dx.doi.org/10.1371/journal.pone.0222331 |
Ejemplares similares
-
Podoplanin is indispensable for cell motility and platelet-induced epithelial-to-mesenchymal transition-related gene expression in esophagus squamous carcinoma TE11A cells
por: Watanabe, Nobuo, et al.
Publicado: (2020) -
Expression of podoplanin and vimentin is correlated with prognosis in esophageal squamous cell carcinoma
por: TANAKA, MAKIKO, et al.
Publicado: (2015) -
A cell-based high-throughput screening assay system for inhibitor compounds of antigen presentation by HLA class II molecule
por: Watanabe, Nobuo, et al.
Publicado: (2017) -
The podoplanin-CLEC-2 axis inhibits inflammation in sepsis
por: Rayes, Julie, et al.
Publicado: (2017) -
Podoplanin and CLEC-2 levels in patients with COVID-19
por: Borba-Junior, Ivanio Teixeira, et al.
Publicado: (2023)